1. Home
  2. RYTM vs CMC Comparison

RYTM vs CMC Comparison

Compare RYTM & CMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$105.64

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$66.15

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
CMC
Founded
2008
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.9B
IPO Year
2017
1994

Fundamental Metrics

Financial Performance
Metric
RYTM
CMC
Price
$105.64
$66.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
9
Target Price
$131.14
$73.33
AVG Volume (30 Days)
872.9K
1.5M
Earning Date
05-05-2026
03-26-2026
Dividend Yield
N/A
1.20%
EPS Growth
28.34
N/A
EPS
N/A
3.96
Revenue
N/A
$7,918,430,000.00
Revenue This Year
$55.34
$18.81
Revenue Next Year
$86.06
$6.34
P/E Ratio
N/A
$16.74
Revenue Growth
N/A
25.57
52 Week Low
$74.50
$49.66
52 Week High
$122.20
$84.87

Technical Indicators

Market Signals
Indicator
RYTM
CMC
Relative Strength Index (RSI) 53.92 47.50
Support Level $98.30 $56.85
Resistance Level $113.51 $72.41
Average True Range (ATR) 4.38 2.03
MACD -1.22 0.51
Stochastic Oscillator 21.67 68.48

Price Performance

Historical Comparison
RYTM
CMC

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About CMC Commercial Metals Company

Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.

Share on Social Networks: